Chromosome:19

PolymorphismGeneLocationStudy
rs25487 (Arg399Gln)XRCC1 19q13.31Povey, Carcinogenesis, 2007
rs25487 (Arg399Gln)XRCC1 19q13.31Li, Carcinogenesis, 2006
rs1799782 (Arg194Trp)XRCC1 19q13.31Han, Br J Cancer, 2004
rs1799780 (C26602T)XRCC1 19q13.31Han, Br J Cancer, 2004
rs25487 (Arg399Gln)XRCC1 19q13.31Han, Br J Cancer, 2004
rs3547 (Gln632Gln)XRCC1 19q13.31Han, Br J Cancer, 2004
rs1799782 (Arg194Trp)XRCC1 19q13.31Winsey, Cancer Res, 2000
rs25487 (Arg399Gln)XRCC1 19q13.31Winsey, Cancer Res, 2000
rs11615ERCC1 19q13.32Povey, Carcinogenesis, 2007
rs11615ERCC1 19q13.32Winsey, Cancer Res, 2000
rs11615ERCC1 19q13.32Tomescu, Carcinogenesis, 2001
rs13181 (Lys751Gln)XPD (ERCC2) 19q13.32Kertat, Oncol Rep, 2008
rs13181 (Lys751Gln)XPD (ERCC2) 19q13.32Povey, Carcinogenesis, 2007
rs1052555 XPD (ERCC2) 19q13.32Povey, Carcinogenesis, 2007
rs238406 (Arg156Arg)XPD (ERCC2) 19q13.32Povey, Carcinogenesis, 2007
rs1799793 (Asp312Asn)XPD (ERCC2) 19q13.32Debniak, Breast Cancer Res Treat, 2006
rs13181 (Lys751Gln)XPD (ERCC2) 19q13.32Debniak, Breast Cancer Res Treat, 2006
rs34517175 (Gly156Gly)XPD (ERCC2) 19q13.32Debniak, Breast Cancer Res Treat, 2006
Arg112HisXPD (ERCC2) 19q13.32Debniak, Breast Cancer Res Treat, 2006
Leu485ProXPD (ERCC2) 19q13.32Debniak, Breast Cancer Res Treat, 2006
rs13181 (Lys751Gln)XPD (ERCC2) 19q13.32Li, Cancer Epidemiol Biomarkers Prev, 2006
rs1799793 (Asp312Asn)XPD (ERCC2) 19q13.32Li, Cancer Epidemiol Biomarkers Prev, 2006
rs13181 (Lys751Gln)XPD (ERCC2) 19q13.32Han, Cancer Epidemiol Biomarkers Prev, 2005
rs1799793 (Asp312Asn)XPD (ERCC2) 19q13.32Han, Cancer Epidemiol Biomarkers Prev, 2005
rs13181 (Lys751Gln)XPD (ERCC2) 19q13.32Baccarelli, Br J Cancer, 2004
rs1799793 (Asp312Asn)XPD (ERCC2) 19q13.32Baccarelli, Br J Cancer, 2004
rs13181 (Lys751Gln)XPD (ERCC2) 19q13.32Tomescu, Carcinogenesis, 2001
rs238406 (Arg156Arg)XPD (ERCC2) 19q13.32Tomescu, Carcinogenesis, 2001
rs1052555 XPD (ERCC2) 19q13.32Tomescu, Carcinogenesis, 2001
rs1799793 (Asp312Asn)XPD (ERCC2) 19q13.32Winsey, Cancer Res, 2000
rs13181 (Lys751Gln)XPD (ERCC2) 19q13.32Winsey, Cancer Res, 2000
rs238406 (Arg156Arg)XPD (ERCC2) 19q13.32Winsey, Cancer Res, 2000
rs488 (T23977C (exon 8,TaqI))CKM 19q13.2Tomescu, Carcinogenesis, 2001
C24800del (3,Ncoll)CKM 19q13.2Tomescu, Carcinogenesis, 2001
rs1800471 (Arg25Pro, TGFB1+915)TGFB119q13.2Howell, Eur J Immunogenet, 2003
rs1799969 (G241R)ICAM1 19p13.2Vinceti, Melanoma Res, 2006
rs5498 (K469E)ICAM1 19p13.2Vinceti, Melanoma Res, 2006
rs1799969 (G241R)ICAM1 19p13.2Howell, Int J Immunogenet, 2005
rs5498 (K469E)ICAM1 19p13.2Howell, Int J Immunogenet, 2005
KIR2DL1 KIR2DL119q13.42Naumova, Cancer Immunol Immunother, 2005
KIR2DL2 KIR2DL2 19q13.42Naumova, Cancer Immunol Immunother, 2005
KIR2DL3 KIR2DL3 19q13.42Naumova, Cancer Immunol Immunother, 2005
KIR3DL1 KIR3DL1 19q13.42Naumova, Cancer Immunol Immunother, 2005
KIR3DL2 KIR3DL2 19q13.42Naumova, Cancer Immunol Immunother, 2005
KIR2DS1 KIR2DS1 19q13.42Naumova, Cancer Immunol Immunother, 2005
KIR2DS2 KIR2DS2 19q13.42Naumova, Cancer Immunol Immunother, 2005
KIR2DS3 KIR2DS3 19q13.42Naumova, Cancer Immunol Immunother, 2005
KIR2DS4 KIR2DS4 19q13.42Naumova, Cancer Immunol Immunother, 2005
KIR3DS1 KIR3DS1 19q13.4Naumova, Cancer Immunol Immunother, 2005
rs1799782 (Arg194Trp)XRCC119q13.31Goncalves, J Dermatol Sci, 2011
rs25487 (Arg399Gln)XRCC119q13.31Goncalves, J Dermatol Sci, 2011
rs13181 (Lys751Gln)XPD (ERCC2) 19q13.32Goncalves, J Dermatol Sci, 2011
C19007T ERCC119q13.32Goncalves, J Dermatol Sci, 2011
rs2043211CARD819q13.33Verma, Pigment Cell Melanoma Res, 2012
KIR2DL3 KIR19q13.42Jose A., Immunogenetics
rs13181 (Lys751Gln)XPD19q13.32Paszkowska-Szczur, IJC 2013
rs1799793XPD19q13.32Paszkowska-Szczur, IJC 2013
rs238406XPD19q13.32Paszkowska-Szczur, IJC 2013

The chromosome graphics
are used after
written permission
from the Map Viewer,
Genome Database,
National Center for
Biotechnology Information,
US National Library
of Medicine.